A Look At Middlemen Fees In 340B Drug Discount Program
By William Sarraille, Shanyue Zeng and Rory Martin · December 3, 2025, 6:06 PM EST
On Oct. 23, the U.S Senate Committee on Health, Education, Labor and Pensions held a hearing on the 340B program, a controversial program that provides heavy discounts to qualifying providers that can...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login